Please wait...
GulfBase Live Support
Leave a message and our representative will contact you soon
- Dubai listed companies buck wider declining GCC trend
- E& shareholders approve 83 fils dividend per share for FY 2024
- Tariffs: GCC banks face limited direct impact; oil prices key
- KACST to set up Quantum Valley with major firms
- Expat remittances from Saudi Arabia hit $3.4bn in February, a 37% annual growth
- Oil Updates - crude edges up on potential US tariff exemptions on cars
- Saudi inflation holds at 2.3% in March amid rising housing and food prices
- Saudi real estate prices rise 4.3% in Q1 on residential sector gains: GASTAT
- Dukhan Bank launches new House Finance campaign
- Doha Bank partners with Ox Fitness Lab
- JAMJOOMPHARMA
- :157.8
- :153
- ('000):70,000
- ( '000):11,046,000
- :0
-
59,304 - :0
- :
- 22.04%
- 26.44%
-
1,328 -
():
9,239,236.6 - ():12,153,323
- :0.76
- Performance Comparison
- :Saudi Stock Exchange
- :Pharma, Biotech & Life Science
- :Small Cap
- :Health Care
Company Overview
- :22/09/1994
- :SAR 700,000,000
- :SAR 10
Activities
Jamjoom Pharmaceuticals Factory is a Saudi joint stock company specialized in developing, manufacturing, marketing and selling generic pharmaceutical products, cosmetics, and healthcare products to consumers. Founded in 2000, the company quickly emerged as one of the leading pharmaceutical companies in the Middle East, Africa and CIS regions. Jamjoom Pharma is ranked among the top 5 pharmaceutical companies globally (IMS) and occupies third place in the total pharmaceutical market in Saudi Arabia (IQVIA). The company has received praise from Frost & Sullivan for its dominance in the pharmaceutical market in Saudi Arabia. In addition, Mr. Nour Sherif, Managing Director, was honored with the European Business Association (EBA) Manager of the Year Award for Innovative Business Strategies. Jamjoom Pharma operates modern manufacturing facilities managed by specialized teams. The company exports its products to more than 30 countries. The company is distinguished by the high quality of its products and its wide distribution network, making it one of the leading companies in the region.
-
Chairman:Mahmoud Y. S. Jamjoom
-
Vice-chairman:Ahmed Y. M. Jamjoom
-
CEO:Tarek Y. Hosni
-
General Manager:
-
Managing Director:
-
Board Members:
Ahmed Y. M. Jamjoom
Alaa Y. M. Salah Jamjoom
Faris I. A. Al-Ghannam
Georges P. Schorderet
Michel M. J. Le Bars
Mohammed Y. M. Jamjoom
Noor A. K. Sheriff
Yousuf M. S. Jamjoom
-
Auditors:
KPMG Professional Services
CFO
Global Manufacturing Officer
Head of Legal Department
HR Director
Commercial Director
| Announced On | Period | As Of | Net Profit (SAR Mil) | Growth (%) |
|---|---|---|---|---|
| 25/02/2025 | 12-Month | 31/12/2024 | 357 | 21.93 |
| 27/10/2024 | 9-Month | 30/09/2024 | 305 | 22.99 |
| 06/08/2024 | 6-Month | 30/06/2024 | 210 | 23 |
| 09/05/2024 | 3-Month | 31/03/2024 | 103 | 22 |
| 25/03/2024 | 12-Month | 31/12/2023 | 292 | 70.68 |
- IR@Jamjoompharma.com
- www.jamjoompharma.com
- P.O. Box 6267 Jeddah 21442
| Market Cap US$ Mil |
Last Price Local Cry |
Price Change (%) 1 Day |
Price Change (%) 1 Year |
P/E TTM | P/B MRQ | Dividend Yield (%) | Beta | ROA (%) | ROE (%) | |
|---|---|---|---|---|---|---|---|---|---|---|
| SULAIMANALHABIB | 26,415.48 | 284 | 0.28 | -2.58 | 44.52 | 0 | 0 | 0 | 0 | 0 |
| PUREHEALTH | 8,105.51 | 2.73 | 1.86 | 0 | 26.51 | 0 | 0 | 0 | 0 | 0 |
| ARMAH | 7,793.69 | 88.9 | -0.12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| NAHDI | 3,949.53 | 114.2 | 0.17 | -15.6 | 17.78 | 0 | 0 | 0 | 0 | 0 |
| MOUWASAT | 3,912.22 | 73.8 | 0.54 | -28.46 | 22.31 | 2.64 | 0 | 0.81 | 13.85 | 22.49 |
| DALLAHHEALTH | 3,337.3 | 127 | -0.94 | -5.63 | 26.59 | 4.66 | 0 | 0.93 | 12.1 | 17.53 |
| FAKEEHCARE | 2,905.92 | 46.75 | -0.54 | 0 | 40.5 | 0 | 0 | 0 | 0 | 0 |
| JAMJOOMPHARMA | 2,857.95 | 157.8 | 3 | 18.09 | 30.69 | 0 | 0 | 0 | 0 | 0 |
| AME | 2,417.69 | 126 | -2.78 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| NABAALSAHA | 1,933.59 | 66 | -4.49 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CARE | 1,790.49 | 146 | -2.54 | -16.19 | 24.48 | 6.96 | 0 | 0.85 | -0.59 | -0.89 |
| TIBBIYAH | 1,766.9 | 33.5 | 1.05 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SAUDIGERMANHEALTH | 1,601.72 | 65.3 | 0 | -28.25 | 28.44 | 3.68 | 0 | 0.79 | 11.92 | 18.76 |
| QOMEL | 1,147.28 | 121 | -1.63 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PROMEDEX | 920.62 | 98 | -0.71 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SPIMACO | 793.74 | 24.2 | -2.5 | -2.21 | 73.56 | 1.13 | 0 | 0.91 | 8.47 | 15.11 |
| ALMUJTAMAMEDICAL | 734.21 | 29 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| AVALONPHARMA | 690.77 | 129.4 | -0.16 | 0 | 32.22 | 0 | 0 | 0 | 0 | 0 |
| MIRAL | 639.6 | 119 | -0.84 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| MIDAN | 529.53 | 797 | 0 | -4.78 | 13.35 | 1.39 | 0 | 0 | 12.06 | 17.87 |
| AYYAN | 411.41 | 15.64 | 1.95 | -8.1 | -7.33 | 1.54 | 0 | 0.81 | -2 | -2.64 |
| GMPC | 390 | 1.99 | -2.93 | 0 | 0 | 1.09 | 3 | -0.08 | 75.81 | 111.42 |
| JULPHAR | 377.34 | 1.19 | -0.84 | 0 | -60.3 | 0.58 | 5.27 | 0.2 | 4.09 | 0 |
| ATC.KW | 369.11 | 715 | -4.67 | 0 | 41.28 | 2.28 | 1.82 | -0.01 | 2.93 | 12.88 |
| MCGS | 348.7 | 4.61 | 1.31 | -0.04 | 21.32 | 0.13 | 5.86 | 0.98 | 6.76 | 7.99 |
| EQUIPMENTHOUSE | 328.59 | 40.7 | -0.98 | 5.1 | 25.64 | 0 | 0 | 0 | 0 | 0 |
| LANA | 287.82 | 30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| RPM | 228.65 | 4.11 | -2.15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| TMC | 216.61 | 22.8 | 12.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| BURJEEL | 205.44 | 1.47 | 1.37 | 0 | 1.61 | 0 | 0 | 0 | 0 | 0 |
| CMCER | 134.61 | 6.41 | -2.29 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| ALMODAWAT | 112.03 | 17.88 | 1.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| FUTURECARE | 88.61 | 6.63 | -0.31 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| QGMD | 43.4 | 1.36 | -1.45 | 16.69 | -2.33 | 0.23 | 0 | 0.76 | -6.18 | 0 |
| SMILECARE | 32.46 | 6 | -1.48 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| BALSMMEDICAL | 25.62 | 76.1 | -1.05 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| ALRAZI | 22.24 | 49.9 | -9.11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| JANA | 19.33 | 21.1 | -6.56 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Financial Information Co.
P.O. Box 69410, Jeddah 11547, Saudi Arabia